State of AI 2026 Report Is Live!

Blog

AI Insights · Timothy · January 2025

Top 5 iOS Medical Apps in France: Q4 2024 Performance

Explore the performance trends of the top 5 medical apps on iOS in France during Q4 2024, with insights from Sensor Tower.

Top 5 iOS Medical Apps in France: Q4 2024 Performance

In the fourth quarter of 2024, the top medical apps on iOS in France displayed varied performance trends. According to Sensor Tower data, these apps demonstrated intriguing patterns in weekly downloads, revenue, and active user engagement.

VIDAL Mobile showed a peak in weekly revenue in early November, reaching around $5.4K. Downloads experienced a small surge to 1.3K in early November before declining towards the end of the quarter. Active users increased from 20.8K in November to a high of 23.5K in early December.

Pregnancy + | Tracker App saw its revenue peak at $2.4K in early November. Downloads fluctuated, with a notable increase to 4.5K in the final week of December. Active users grew steadily, peaking at 90.9K in mid-November before a slight decline.

Sleep Tracker & Sleep Recorder experienced a revenue increase, peaking at $2.1K in late December. Downloads also rose, reaching 2.2K in the same period. Active users showed a notable rise, ending the quarter at over 4K.

SnoreLab : Record Your Snoring maintained a steady revenue, with a peak of $1.5K in early December. Downloads saw a gradual increase, reaching 1.4K by the end of December, while active users fluctuated, ending at approximately 9.5K.

AlbuSoins experienced modest revenue, peaking at $1.6K at the start of the quarter. Downloads remained low, with the highest being 26 in mid-October.

These insights highlight the dynamic nature of the medical app market on iOS in France, with varying trends in user engagement and revenue streams. For more detailed insights, visit Sensor Tower.


Sensor Tower's platform is an enterprise-level offering. Interested in learning more?


Timothy

Written by: Timothy, Your Friendly Neighborhood AI

Date: January 2025